Profile data is unavailable for this security.
About the company
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
- Revenue in USD (TTM)296.92m
- Net income in USD-10.20m
- Incorporated2018
- Employees584.00
- LocationTransmedics Group Inc200 Minuteman RoadANDOVER 01810United StatesUSA
- Phone+1 (978) 552-0900
- Websitehttps://www.transmedics.com/
Mergers & acquisitions
Acquired company | TMDX:NMQ since announced | Transaction value |
---|---|---|
Summit Aviation Inc | 44.32% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inari Medical Inc | 520.66m | -23.62m | 2.91bn | 1.30k | -- | 6.48 | -- | 5.58 | -0.409 | -0.409 | 8.95 | 7.71 | 0.8913 | 1.58 | 7.75 | 400,506.90 | -4.04 | -0.5941 | -4.57 | -0.6696 | 87.67 | 89.06 | -4.54 | -0.6295 | 2.19 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
LivaNova PLC | 1.19bn | -31.77m | 3.31bn | 2.90k | -- | 2.71 | 196.51 | 2.79 | -0.5911 | -0.5911 | 21.89 | 22.56 | 0.4985 | 2.57 | 6.11 | 408,634.10 | -1.33 | -6.01 | -1.54 | -7.42 | 67.89 | 66.99 | -2.67 | -13.56 | 2.71 | 2.52 | 0.3383 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
Tandem Diabetes Care Inc | 770.01m | -141.45m | 3.31bn | 2.40k | -- | 13.61 | -- | 4.30 | -2.17 | -2.17 | 11.82 | 3.76 | 0.8126 | 2.74 | 8.35 | 320,837.10 | -14.93 | -10.08 | -18.48 | -12.23 | 49.28 | 51.77 | -18.37 | -11.59 | 3.01 | -- | 0.5884 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
Envista Holdings Corp | 2.56bn | -120.40m | 3.33bn | 12.80k | -- | 0.8038 | 305.25 | 1.30 | -0.713 | -0.713 | 14.72 | 24.09 | 0.3904 | 3.89 | 6.29 | 200,226.60 | -1.83 | 1.94 | -2.15 | 2.34 | 56.35 | 57.65 | -4.70 | 5.29 | 1.93 | 5.09 | 0.2667 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
Procept Biorobotics Corp | 156.33m | -103.37m | 3.41bn | 626.00 | -- | 12.92 | -- | 21.84 | -2.12 | -2.12 | 3.20 | 5.14 | 0.4685 | 1.81 | 4.08 | 249,722.00 | -30.98 | -- | -34.68 | -- | 53.47 | -- | -66.12 | -- | 7.44 | -- | 0.1629 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
Axonics Inc | 387.14m | -15.95m | 3.42bn | 797.00 | -- | 5.46 | -- | 8.84 | -0.3134 | -0.3134 | 7.76 | 12.29 | 0.5606 | 1.20 | 8.53 | 485,744.00 | -2.31 | -12.67 | -2.52 | -13.76 | 75.25 | 70.04 | -4.12 | -29.68 | 8.04 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
Integer Holdings Corp | 1.63bn | 98.09m | 4.06bn | 10.50k | 42.10 | 2.66 | 20.41 | 2.49 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.91 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.54 | 26.94 | 6.01 | 6.40 | 2.01 | 3.74 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
Haemonetics Corporation | 1.31bn | 117.56m | 4.27bn | 3.66k | 36.76 | 4.45 | 19.90 | 3.27 | 2.29 | 2.29 | 25.47 | 18.90 | 0.6339 | 2.10 | 6.79 | 357,958.70 | 5.69 | 5.02 | 6.57 | 6.07 | 53.69 | 51.74 | 8.98 | 8.11 | 1.50 | 18.09 | 0.457 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
TransMedics Group Inc | 296.92m | -10.20m | 4.49bn | 584.00 | -- | 28.10 | 4,102.87 | 15.13 | -0.335 | -0.335 | 8.96 | 4.85 | 0.5874 | 3.08 | 4.93 | 508,422.90 | -2.02 | -16.08 | -2.19 | -17.95 | 62.40 | 65.37 | -3.43 | -40.47 | 8.76 | -- | 0.7607 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Merit Medical Systems Inc | 1.28bn | 101.95m | 4.72bn | 6.95k | 46.53 | 3.80 | 24.18 | 3.67 | 1.74 | 1.74 | 21.96 | 21.35 | 0.64 | 2.32 | 7.32 | 184,648.80 | 5.08 | 2.45 | 5.65 | 2.77 | 46.54 | 44.50 | 7.94 | 3.91 | 4.38 | 11.61 | 0.3922 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
Inspire Medical Systems Inc | 660.91m | -15.73m | 4.72bn | 1.01k | -- | 8.00 | -- | 7.14 | -0.5374 | -0.5374 | 22.46 | 19.85 | 1.05 | 3.14 | 10.01 | 653,721.10 | -2.50 | -11.27 | -2.80 | -12.60 | 84.65 | 84.47 | -2.38 | -13.57 | 7.25 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
Lantheus Holdings Inc | 1.37bn | 460.53m | 5.67bn | 834.00 | 12.49 | 6.00 | 10.88 | 4.15 | 6.55 | 6.55 | 19.42 | 13.64 | 0.8587 | 8.78 | 4.71 | 1,637,434.00 | 28.96 | 6.69 | 34.54 | 7.73 | 64.02 | 53.90 | 33.72 | 9.02 | 4.55 | -- | 0.3733 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
Glaukos Corp | 326.43m | -140.87m | 5.68bn | 907.00 | -- | 12.47 | -- | 17.39 | -2.88 | -2.88 | 6.68 | 9.04 | 0.3426 | 1.72 | 7.74 | 359,905.20 | -14.78 | -8.73 | -15.91 | -9.35 | 76.18 | 74.77 | -43.16 | -28.69 | 4.68 | -38.38 | 0.4395 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
DENTSPLY SIRONA Inc | 3.94bn | -95.00m | 5.82bn | 15.00k | -- | 1.78 | 22.99 | 1.48 | -0.4468 | -0.4468 | 18.69 | 15.69 | 0.5326 | 2.94 | 6.02 | 262,666.70 | -1.24 | -1.14 | -1.52 | -1.32 | 52.61 | 53.65 | -2.34 | -2.51 | 0.9692 | 3.27 | 0.3908 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
Novanta Inc | 893.45m | 69.29m | 5.82bn | 2.90k | 84.39 | 8.54 | 49.71 | 6.51 | 1.92 | 1.92 | 24.77 | 18.99 | 0.6778 | 2.99 | 6.11 | 308,086.90 | 5.26 | 5.46 | 5.92 | 6.34 | 45.07 | 43.24 | 7.76 | 7.71 | 1.77 | 4.42 | 0.4319 | 0.00 | 2.41 | 7.49 | -1.58 | 8.21 | 4.19 | -- |
Holder | Shares | % Held |
---|---|---|
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 4.44m | 13.58% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 2.27m | 6.94% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.80m | 5.49% |
Macquarie Investment Management Business Trustas of 31 Mar 2024 | 1.30m | 3.97% |
Driehaus Capital Management LLCas of 31 Mar 2024 | 1.28m | 3.92% |
Invesco Advisers, Inc.as of 31 Mar 2024 | 1.26m | 3.86% |
Eventide Asset Management LLCas of 31 Mar 2024 | 1.17m | 3.58% |
ArrowMark Colorado Holdings LLCas of 31 Mar 2024 | 1.08m | 3.30% |
Credit Suisse Asset Management (Schweiz) AGas of 31 Mar 2024 | 842.15k | 2.57% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 774.88k | 2.37% |